IP Library › Granted Patent US 12,702,692
Granted Patent B2
US 12,702,692 · App. 18/012,290 · Granted Aug 11, 2026

Therapeutic use of calcium-activated chloride channel peptide activator

Inventors: Guillaume Sandoz (Antibes, FR); Pablo Avalos Prado (Nice, FR); Jacques Barhanin (Nice, FR)
Assignees: CENTRE NATIONAL DE LA; RECHERCHE SCIENTIFIQUE UNIVERSITÉ CÔTE D'AZUR; INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
A61K38/10A61P43/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,702,692
App. No.
18/012,290
Granted
Aug 11, 2026
Kind
B2
Abstract

The present disclosure relates to a calcium-activated chloride channel peptide activator and its therapeutic use.

Claims (2)

1 . A pharmaceutical composition comprising PBS with a TMEM16A peptide activator

consisting of an amino acid sequence L-A-R-R-S-P-R-S-S-D-G-K-L (SEQ ID NO: 2), wherein the TMEM16A peptide activator has a concentration of 10 mM or 100 μm.